Stay updated on GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Sign up to get notified when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.

Latest updates to the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page
- Check4 days agoChange DetectedPage updated to Revision: v3.0.2, replacing v3.0.1; a minor UI element 'Back to Top' was removed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as the introduction of new drug safety topics. Notably, the term 'Glatiramer Acetate' has been retained despite its deletion in a previous context, indicating a focus on this drug's relevance.SummaryDifference7%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.